The Federal Institute of Technology in Lausanne (EPFL), the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have pooled their resources to create Switzerland’s first ever genome center. Located on Campus Biotech in Geneva, the new platform aims to make gene sequencing more widely available and thus to promote personalized healthcare and precision medicine across Switzerland. It will provide its services to the university hospitals of Geneva, Lausanne (CHUV) and Bern (Inselspital), as well as to partner universities. The center is expected to employ up to 40 people.

The establishment of the Swiss genome center is part of the nationwide Health 2030 initiative, designed to foster research, training and services in the field of digital and personalized health in Western Switzerland. The region has globally recognized expertise in genomics.

Campus Biotech as a global hub for genetics research

The Swiss genome center is not the only newcomer to Campus Biotech. The former Merck Serono site will also play host to the Bertarelli Foundation Gene Therapy Platform, whose goals include coming up with viral vectors in the effort to develop drugs capable of acting directly on defective parts of DNA.